Xpert Bladder Cancer Monitor

DIAGNOSTIC_TEST4 trials

Sponsors

Cepheid, Mansoura University, Jørgen Bjerggaard Jensen

Conditions

Bladder CancerNon-muscle Invasive Bladder CancerNon-muscle-invasive Bladder CancerUrinary Biomarker

Unknown Phase

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

CompletedNCT03125460

CepheidBladder Cancer

Start: 2016-12-31End: 2019-05-31Updated: 2020-02-07

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

CompletedNCT03664258

CepheidNon-muscle-invasive Bladder Cancer

Start: 2018-06-06End: 2022-01-31Updated: 2023-02-13

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

CompletedNCT03715660

Mansoura UniversityBladder Cancer

Start: 2018-03-01End: 2019-10-01Updated: 2019-11-21

Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor

Active, not recruitingNCT04100733

Jørgen Bjerggaard JensenNon-muscle Invasive Bladder Cancer, Urinary Biomarker

Start: 2019-11-01End: 2027-04-30Target: 392Updated: 2023-06-01